Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy.

At the end of a single treatment cycle, triple therapy yielded the highest frequency of tumors <400 mm 3 (88.2%), approaching significance versus Entinostat+NHS-IL12 (58.8%, p=0.0519), and significantly higher versus all other treatment cohorts ( figure 1G , online supplemental table 2 ).

also in 2,640 other papers